The facility will lifesaving treatment to up to 120 Children with hereditary blood disorders like thalassemia

DKMS Foundation India inaugurated a new Bone Marrow Transplant (BMT) Unit in Ahmedabad. Designed to meet the growing demand for stem cell transplantations in the region, the new centre includes 10 specialised pediatric BMT beds, essential apheresis care facilities and an outpatient center.

More than 26 professionals, including four doctors and 14 nurses, will ensure patient care. The non-profit organisation Sankalp India Foundation operates the new unit with the medical advice support of Cure2Children on the premises of Health1 Super Specialty Hospital, Ahmedabad.

DKMS through its Access to Transplantation programme has committed Rs 3.1 crore (approximately 350,000 euros) to fund the new BMT unit.

“By funding the BMT unit in Ahmedabad, we are bringing lifesaving care closer to home, reducing barriers to treatment, and supporting families who might otherwise have to travel long distances. We dream of giving every child suffering from thalassemia in India a second chance at life – a chance to smile, grow, and embrace the future they deserve,” explains Dr Elke Neujahr, Global CEO, DKMS.

“Our collaboration with DKMS has transformed the lives of more than 570 children in India since 2018,” says Rajat Kumar Agarwal, President, Sankalp. “With the new and expanded unit in Ahmedabad, where up to 120 children can be treated every year, even more children can be saved and return to a happy life. It represents hope and a brighter future for families facing the challenges of thalassemia.”